Skip to main content
. 2017 Oct 27;8(57):97504–97515. doi: 10.18632/oncotarget.22146

Figure 4. The diagnostic significance of Jab1/COPS5 was analyzed via establishing ROC curve in cancer.

Figure 4

The curve demonstrated that Jab1/COPS5 could discriminate between responder and non-responder of chemotherapy in lung cancer (A), or non-relapse and relapse in breast cancer (B).